The United States Patent and Trademark Office (USPTO) has issued a design patent, USD1120290S1, for a pharmaceutical tablet. The patent was granted to Eli Lilly and Company and lists Melissa Paige Keeney, James Edwin Miesle, and Jonathan Brett Wade as inventors. The filing date for the application was May 13, 2020, and the patent is officially dated March 24, 2026.

This patent grant is primarily an intellectual property matter and does not impose new regulatory obligations or compliance requirements on drug manufacturers. It signifies the protection of a specific design element related to pharmaceutical tablets. Companies in the pharmaceutical sector should note this grant as it pertains to the patent landscape for tablet design, potentially impacting future product development and intellectual property strategies.